Table 1. Clinical characteristics of the study population.
Characteristic | Total (N=234) | TGCV (n=104) | non-TGCV (n=130) | p-value/FDR adjusted p-value | |
---|---|---|---|---|---|
|
Age (years) |
63.3 ± 13.7 |
64.6 ± 12.9 |
62.3 ± 14.3 |
0.21/0.62 |
|
Sex (male) |
173 (74%) |
77 (74%) |
96 (74%) |
0.97/0.97 |
|
Height (cm) |
163 ± 9.3 |
163 ± 9.8 |
163 ± 9.0 |
0.95/0.97 |
|
Body weight (kg) |
62.0 ± 14.5 |
61.7 ± 14.8 |
62.3 ± 14.3 |
0.79/0.95 |
|
Body mass index (kg/m2) |
23.1 ± 4.3 |
23.0 ± 4.2 |
23.2 ± 4.4 |
0.74/0.95 |
Coronary artery disease | Total 146 (62%) | Total 78 (75%) | Total 68 (52%) | 0.0004/0.004 | |
|
|||||
Heart | Coronary artery disease (details) | 1-vessel 28 (12%) | 1-vessel 14 (13%) | 1-vessel 14 (11%) | |
2-vessel 37 (16%) | 2-vessel 20 (19%) | 2-vessel 17 (13%) | |||
3-vessel 54 (23%) | 3-vessel 31 (30%) | 3-vessel 23 (18%) | |||
LMT 15 (6%) | LMT 8 (8%) | LMT 7 (5%) | |||
CSA 18 (8%) | CSA 10 (10%) | CSA 8 (6%) | |||
| |||||
Heart failure or cardiac dysfunction of unknown etiology |
47 (20%) |
22 (21%) |
25(20%) |
0.72/0.95 |
|
Post-resuscitation |
14 (6%) |
8 (8%) |
6 (5%) |
0.32/0.78 |
|
LVEF (%) | 41.1 ± 18.7 | 38.1 ± 18.0 | 43.6 ± 18.9 | 0.026/0.15 | |
| |||||
Hypertension |
97 (41%) |
45 (43%) |
52 (40%) |
0.61/0.95 |
|
Comorbidity | Diabetes mellitus |
113 (48%) |
58 (56%) |
55 (42%) |
0.041/0.16 |
Dyslipidemia |
101 (43%) |
43 (41%) |
58 (45%) |
0.62/0.95 |
Continuous values were reported as mean ± standard deviation. Demographic and clinical characteristics were compared between TGCV and non-TGCV using Welch's t tests for continuous variables and chi-square tests for binary variables. Multiple comparison was performed using Benjamini-Hochberg procedure with false discovery rate threshold of 0.05.
CSA: Coronary spastic angina, FDR: False discovery rate, LMT: Left main trunk, LVEF: Left ventricular ejection fraction